Liver cancer is the most common fatal malignancy globally and ranks fifth in the United States. It often presents in advanced stages, leading to poor prognosis. Over 90% of liver cancers are hepatocellular carcinomas (HCC), with chemotherapy and immunotherapy as primary treatment options. However, current treatments have limited efficacy and significant side effects. Natural compounds and nanotechnology offer promising alternatives with reduced toxicity and improved outcomes. Natural compounds like piperine, curcumin, and oleocanthal exhibit anti-cancer properties by inducing apoptosis, inhibiting cell proliferation, and reducing inflammation. These compounds can enhance the effectiveness of existing therapies. For example, piperine increases drug bioavailability and selectively targets cancer cells, while curcumin synergizes with piperine to enhance antitumor effects. Oleocanthal inhibits HCC cell growth and induces apoptosis, showing selectivity for cancer cells over normal cells. Chemotherapy, particularly sorafenib, is the first-line treatment for advanced HCC, but resistance and severe side effects limit its effectiveness. Combination therapies with other drugs, such as doxorubicin, show improved outcomes. However, resistance remains a challenge, and new approaches are needed. Immunotherapy, including immune checkpoint inhibitors like PD-1 and PD-L1 blockers, enhances the immune system's ability to attack cancer cells. These therapies, combined with existing treatments, show promise in improving survival rates. Vaccines and oncolytic viruses also offer potential in targeting cancer cells. Nanotechnology improves drug delivery, enhances targeting, and reduces systemic toxicity. Nanoparticles can deliver chemotherapy agents more effectively, increasing their concentration at tumor sites while minimizing damage to healthy cells. This approach enhances the efficacy of treatments and reduces side effects. Despite advancements, liver cancer remains a significant health challenge. Continued research into natural compounds, immunotherapy, and nanotechnology is essential to improve treatment outcomes and reduce mortality. New strategies, including combination therapies and targeted approaches, are being explored to enhance the effectiveness of current treatments and improve patient survival.Liver cancer is the most common fatal malignancy globally and ranks fifth in the United States. It often presents in advanced stages, leading to poor prognosis. Over 90% of liver cancers are hepatocellular carcinomas (HCC), with chemotherapy and immunotherapy as primary treatment options. However, current treatments have limited efficacy and significant side effects. Natural compounds and nanotechnology offer promising alternatives with reduced toxicity and improved outcomes. Natural compounds like piperine, curcumin, and oleocanthal exhibit anti-cancer properties by inducing apoptosis, inhibiting cell proliferation, and reducing inflammation. These compounds can enhance the effectiveness of existing therapies. For example, piperine increases drug bioavailability and selectively targets cancer cells, while curcumin synergizes with piperine to enhance antitumor effects. Oleocanthal inhibits HCC cell growth and induces apoptosis, showing selectivity for cancer cells over normal cells. Chemotherapy, particularly sorafenib, is the first-line treatment for advanced HCC, but resistance and severe side effects limit its effectiveness. Combination therapies with other drugs, such as doxorubicin, show improved outcomes. However, resistance remains a challenge, and new approaches are needed. Immunotherapy, including immune checkpoint inhibitors like PD-1 and PD-L1 blockers, enhances the immune system's ability to attack cancer cells. These therapies, combined with existing treatments, show promise in improving survival rates. Vaccines and oncolytic viruses also offer potential in targeting cancer cells. Nanotechnology improves drug delivery, enhances targeting, and reduces systemic toxicity. Nanoparticles can deliver chemotherapy agents more effectively, increasing their concentration at tumor sites while minimizing damage to healthy cells. This approach enhances the efficacy of treatments and reduces side effects. Despite advancements, liver cancer remains a significant health challenge. Continued research into natural compounds, immunotherapy, and nanotechnology is essential to improve treatment outcomes and reduce mortality. New strategies, including combination therapies and targeted approaches, are being explored to enhance the effectiveness of current treatments and improve patient survival.